MDM2 SNP309 and TP53 SNPArg72Pro Polymorphisms in Myelodysplastic Syndrome.

被引：0
|
作者：
Machado Neto, Joao Agostinho [1 ]
Traina, Fabiola [1 ]
Campos, Paula Melo [1 ]
Andreoli, Marilisia [1 ]
Metze, Irene Lorand [1 ]
Costa, Fernando Ferreira [1 ]
Saad, Sara T. O. [1 ]
机构：
[1] Univ Estadual Campinas, Hematol & Hemotherapy Ctr, Campinas, SP, Brazil
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
MDM2; p53; myelodysplasia; polymorphisms;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：693 / 694
页数：2
相关论文
共 50 条
  • [41] Association of the germline TP53 R72P and MDM2 SNP309 variants with breast cancer survival in specific breast tumor subgroups
    He, Xiao-Feng
    Su, Jiao
    Zhang, Ying
    Huang, Xian
    Liu, Yi
    Ding, Da-Peng
    Wang, Wei
    Arparkorn, K.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 130 (02) : 517 - 529
  • [42] The significance of MDM2 SNP309 and p53 Arg72Pro in young women with breast cancer
    Lang, Anna
    Wegman, Pia Palmeback
    Wingren, Sten
    ONCOLOGY REPORTS, 2009, 22 (03) : 575 - 579
  • [43] Gene Polymorphisms Of P53 At Codon 72 And Mdm2 Snp309 Are Associated With Emphysematous Changes In COPD Patients
    Mizuno, S.
    Ishizaki, T.
    Kadowaki, M.
    Gomez-Arroyo, J. G.
    Kraskauskas, D.
    Voelkel, N. F.
    Osanai, K.
    Toga, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [44] Association of the germline TP53 R72P and MDM2 SNP309 variants with breast cancer survival in specific breast tumor subgroups
    Alexandra J. van den Broek
    Annegien Broeks
    Hugo M. Horlings
    Sander V. M. Canisius
    Linde M. Braaf
    Anita Langerød
    Laura J. Van’t Veer
    Marjanka K. Schmidt
    Breast Cancer Research and Treatment, 2011, 130 : 599 - 608
  • [45] Impact of TP53 Codon 72 and MDM2 SNP 309 Polymorphisms in Pancreatic Ductal Adenocarcinoma (vol 10, e0118829, 2015)
    Hori, Y.
    Miyabe, K.
    Yoshida, M.
    Nakazawa, T.
    Hayashi, K.
    Naitoh, I
    PLOS ONE, 2015, 10 (04):
  • [46] Effect of TP53 codon 72 and MDM2 SNP309 polymorphisms on survival of gastric cancer among patients who receiving 5-fluorouracil-based postoperative adjuvant chemotherapy
    Wang, Shizhi
    Chen, Lulu
    Zhao, Qinghong
    Rong, Huan
    Wang, Meilin
    Gong, Weida
    Zhou, Jianwei
    Wu, Dongmei
    Zhang, Zhengdong
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (04) : 1073 - 1082
  • [47] MDM2 gene amplification is correlated to tumor progression but not to the presence of SNP309 or TP53 mutational status in primary colorectal cancers
    Forslund, Ann
    Zeng, Zhaoshi
    Qin, Li-Xuan
    Rosenberg, Shoshana
    Ndubuisi, MacKevin
    Pincas, Hanna
    Gerald, William
    Notterman, Daniel A.
    Barany, Francis
    Paty, Philip B.
    MOLECULAR CANCER RESEARCH, 2008, 6 (02) : 205 - 211
  • [48] Effect of TP53 codon 72 and MDM2 SNP309 polymorphisms on survival of gastric cancer among patients who receiving 5-fluorouracil-based postoperative adjuvant chemotherapy
    Shizhi Wang
    Lulu Chen
    Qinghong Zhao
    Huan Rong
    Meilin Wang
    Weida Gong
    Jianwei Zhou
    Dongmei Wu
    Zhengdong Zhang
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 1073 - 1082
  • [49] Effects of p53 Codon 72 and MDM2 SNP309 Polymorphisms on Gastric Cancer Risk among the Iranian Population
    Moradi, Mohammad-Taher
    Salehi, Zivar
    Aminian, Keyvan
    Yazdanbod, Abbas
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (17) : 7413 - 7417
  • [50] MDM2 SNP309 and risk of endometrial cancer
    Knappskog, Stian
    Lonning, Per Eystein
    TUMOR BIOLOGY, 2014, 35 (08) : 7285 - 7286
12345